Sanofi
SNY
SNY
640 hedge funds and large institutions have $12.7B invested in Sanofi in 2022 Q4 according to their latest regulatory filings, with 119 funds opening new positions, 202 increasing their positions, 206 reducing their positions, and 55 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
9% more funds holding
Funds holding: 586 → 640 (+54)
0.58% more ownership
Funds ownership: 20.12% → 20.69% (+0.58%)
2% less repeat investments, than reductions
Existing positions increased: 202 | Existing positions reduced: 206
Holders
640
Holding in Top 10
17
Calls
$145M
Puts
$66.5M
Top Buyers
| 1 | +$414M | |
| 2 | +$119M | |
| 3 | +$100M | |
| 4 |
MSE
MUFG Securities EMEA
London,
United Kingdom
|
+$96.3M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$91.2M |
Top Sellers
| 1 | -$456M | |
| 2 | -$89.3M | |
| 3 | -$66.6M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$59.5M |
| 5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$31.7M |